RS67304A - Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles - Google Patents

Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles

Info

Publication number
RS67304A
RS67304A YU67304A YUP67304A RS67304A RS 67304 A RS67304 A RS 67304A YU 67304 A YU67304 A YU 67304A YU P67304 A YUP67304 A YU P67304A RS 67304 A RS67304 A RS 67304A
Authority
RS
Serbia
Prior art keywords
solid amorphous
dried solid
pressure nozzles
amorphous drug
homogeneous spray
Prior art date
Application number
YU67304A
Other languages
English (en)
Inventor
Ronald Arthur Beyerinck
Roderick Jack Ray
Daniel Elmont Dobry
Dana Marie Settell
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27663274&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS67304(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of RS67304A publication Critical patent/RS67304A/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Glanulating (AREA)
  • Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)
  • Disintegrating Or Milling (AREA)

Abstract

Homogene čvrste amorfne disperzije leka u polimerima koji povećavaju rastvorljivost su stvorene u željenim većim veličinama čestica sa minimumom sitnozrnih čestica upotrebom raspršivača i uslova sposobnih da proizvedu kapljice koje imaju srednji prečnik od najmanje 50 mikrona i D10 od najmanje 10 mikrona.
YU67304A 2002-02-01 2003-01-20 Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles RS67304A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35398602P 2002-02-01 2002-02-01
PCT/IB2003/000120 WO2003063821A2 (en) 2002-02-01 2003-01-20 Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles

Publications (1)

Publication Number Publication Date
RS67304A true RS67304A (en) 2006-10-27

Family

ID=27663274

Family Applications (1)

Application Number Title Priority Date Filing Date
YU67304A RS67304A (en) 2002-02-01 2003-01-20 Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles

Country Status (20)

Country Link
US (1) US7780988B2 (sr)
EP (1) EP1469830A2 (sr)
JP (1) JP2005523260A (sr)
KR (1) KR100758045B1 (sr)
CN (1) CN1787808A (sr)
AR (1) AR038369A1 (sr)
AU (1) AU2003239463B2 (sr)
BR (1) BR0307515A (sr)
CA (1) CA2474958A1 (sr)
GT (1) GT200300024A (sr)
MX (1) MXPA04007435A (sr)
PA (1) PA8565401A1 (sr)
PE (1) PE20030804A1 (sr)
PL (1) PL371593A1 (sr)
RS (1) RS67304A (sr)
RU (1) RU2288703C2 (sr)
TW (1) TW200404576A (sr)
UY (1) UY27645A1 (sr)
WO (1) WO2003063821A2 (sr)
ZA (1) ZA200405971B (sr)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
KR100758045B1 (ko) 2002-02-01 2007-09-11 화이자 프로덕츠 인크. 압력 노즐을 이용하여 균질한 분무 건조된 비결정질 고체약물 분산제를 제조하는 방법
BR0307333A (pt) 2002-02-01 2004-12-07 Pfizer Prod Inc Métodos para a preparação de dispersões homogéneas de fármacos sólidos amorfos atomizados utilizando um sistema de secagem por pulverização
CL2004001884A1 (es) * 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
CA2560984A1 (en) 2004-06-01 2005-12-15 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Process for preparation of amorphous form of a drug
EP2489659B1 (en) 2004-06-24 2017-12-13 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
JP2007519757A (ja) 2004-12-01 2007-07-19 テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ ピメクロリマスの調製方法
US9265731B2 (en) 2005-01-28 2016-02-23 Bend Research, Inc. Drying of drug-containing particles
US20100047338A1 (en) 2008-03-14 2010-02-25 Angela Brodie Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
WO2007016435A2 (en) 2005-07-28 2007-02-08 Isp Investments Inc. Method to improve characteristics of spray dried powders and granulated materials, and the products thereby produced
WO2007072869A1 (ja) * 2005-12-21 2007-06-28 Eisai R & D Management Co., Ltd. １，２－ジヒドロピリジン化合物の非晶質体
ES2790700T3 (es) 2005-12-28 2020-10-28 Vertex Pharma Composiciones farmacéuticas de la forma amorfa de N-[2,4-bis(1,1-dimetiletil)-5-hidroxifenil]-1,4-dihidro-4-oxoquinolin-3-carboxamida
EP1983966B1 (en) 2006-02-09 2013-06-26 Merck Sharp & Dohme Corp. Polymer formulations of cetp inhibitors
CN101453989B (zh) 2006-06-06 2012-06-13 泰博特克药品有限公司 制备tmc125喷雾干燥制剂的方法
EP2043610B1 (en) 2006-07-21 2015-07-01 Bend Research, Inc. Drying of drug-containing particles
US8613946B2 (en) 2006-12-21 2013-12-24 Isp Investment Inc. Carotenoids of enhanced bioavailability
CN101622302B (zh) 2007-01-26 2013-01-23 Isp投资公司 生产喷雾干燥产品的制剂工艺方法
EP2046777A2 (en) 2007-05-01 2009-04-15 Plus Chemicals B.V. Amorphous eletriptan hydrobromide and process for preparing it and other forms of eletriptan hydrobromide
CN102686600A (zh) 2009-02-05 2012-09-19 托凯药业股份有限公司 甾体cyp17抑制剂/抗雄激素物质的新型药物前体
BRPI1011506B8 (pt) 2009-03-20 2021-05-25 Vertex Pharma processo para a fabricação de moduladores de regulador de condutância de transmembrana de fibrose cística
EP3130396B1 (en) * 2009-03-27 2021-03-17 Bend Research, Inc. Spray-drying process
EP3175844A1 (en) * 2010-04-09 2017-06-07 Pacira Pharmaceuticals, Inc. Large diameter synthetic membrane vesicles
MX2012014387A (es) 2010-06-09 2013-05-01 Abbvie Inc Dispersiones solidas que contienen inhibidores de cinasa.
JP5847813B2 (ja) * 2010-06-23 2016-01-27 シマベイ セラピューティクス， インコーポレーテッド ５−エチル−２−｛４−［４−（４−テトラゾル−１−イル−フェノキシメチル）−チアゾール−２−イル］−ピペリジン−１−イル｝−ピリミジンの組成物
EP2611529B1 (en) 2010-09-03 2019-01-23 Bend Research, Inc. Spray-drying method
EP2611530B1 (en) 2010-09-03 2019-01-16 Bend Research, Inc. Spray-drying apparatus and methods of using the same
US9248584B2 (en) 2010-09-24 2016-02-02 Bend Research, Inc. High-temperature spray drying process and apparatus
CA2823628A1 (en) 2011-01-05 2012-07-12 Hospira, Inc. Spray drying vancomycin
TWI590821B (zh) * 2011-01-18 2017-07-11 輝瑞有限公司 固體分子分散液
PT106063B (pt) * 2011-12-19 2017-05-30 Inst Superior Técnico Minociclina cristalina termorresistente produzida por recristalização com dióxido de carbono
CN104470518A (zh) 2012-02-27 2015-03-25 沃泰克斯药物股份有限公司 药物组合物及其施用
RU2759837C2 (ru) 2012-05-31 2021-11-18 Мерк Шарп И Доум Корп. Составы твердых дозированных лекарственных форм антагониста орексинового рецептора
PL3725778T3 (pl) * 2012-09-11 2021-12-20 Medivation Prostate Therapeutics Llc Preparaty enzalutamidu
US20140212491A1 (en) 2013-01-31 2014-07-31 Gilead Pharmasset Llc Combination formulation of two antiviral compounds
KR20150139830A (ko) 2013-02-01 2015-12-14 글리아로직스 인코포레이티드 신경변성 및 기타 질환의 치료를 위한 조성물 및 방법
EP2968370A4 (en) 2013-03-14 2016-09-21 Univ Maryland AGENT FOR ANDROGEN RECEPTOR DOWNWARD CONTROL AND USES THEREOF
CN104043104B (zh) 2013-03-15 2018-07-10 浙江创新生物有限公司 含盐酸万古霉素的喷雾干粉及其工业化制备方法
JP2016528252A (ja) 2013-08-12 2016-09-15 トーカイ ファーマシューティカルズ， インコーポレイテッド アンドロゲン標的治療を使用する新生物障害の処置のためのバイオマーカー
EP4005560A1 (en) 2013-08-27 2022-06-01 Gilead Pharmasset LLC Combination formulation of two antiviral compounds
CN103694903B (zh) * 2013-12-02 2015-07-01 南通瑞普埃尔生物工程有限公司 一种瞬干胶粘剂及其制备方法
US20160303102A1 (en) * 2013-12-05 2016-10-20 Alrise Biosystems Gmbh Process for the production of drug formulations for oral administration
JP6649378B2 (ja) * 2014-07-25 2020-02-19 ローラン・ファーマシューティカルズ フェンレチニドの固体経口処方物
US10406127B2 (en) 2014-07-25 2019-09-10 Laurent Pharmaceuticals Solid oral formulation of fenretinide
WO2016057730A1 (en) 2014-10-07 2016-04-14 Strohmeier Mark Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator
CA2962719A1 (en) 2014-10-31 2016-05-06 Bend Research Inc. Process for forming active domains dispersed in a matrix
MA41107A (fr) * 2014-12-05 2017-10-10 Aragon Pharmaceuticals Inc Compositions anti-cancéreuses
CA2969675C (en) 2014-12-05 2023-06-06 Aragon Pharmaceuticals, Inc. Anticancer compositions
RU2585023C1 (ru) * 2014-12-18 2016-05-27 Общество с ограниченной ответственностью "Нанолек" Способ гранулирования
JP2019511542A (ja) 2016-04-15 2019-04-25 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー カプシド集合阻害剤を含む組み合わせ及び方法
GB201609222D0 (en) 2016-05-25 2016-07-06 F2G Ltd Pharmaceutical formulation
WO2018075865A1 (en) 2016-10-21 2018-04-26 Glialogix, Inc. Compositions for the treatment of neurodegenerative diseases
US10973801B2 (en) 2018-03-14 2021-04-13 Janssen Sciences Ireland Unlimited Company Capsid assembly modulator dosing regimen
MX2021001063A (es) 2018-07-30 2021-04-12 Chugai Pharmaceutical Co Ltd Dispersion solida de derivado de hidantoina.
US11819503B2 (en) 2019-04-23 2023-11-21 F2G Ltd Method of treating coccidioides infection
TW202136258A (zh) 2019-12-30 2021-10-01 美商迪賽孚爾製藥有限公司 １—（４—溴—５—（１—乙基—７—（甲胺基）—２—側氧基—１，２—二氫—１，６—萘啶—３—基）—２—氟苯基）—３—苯脲組合物
KR20220123057A (ko) 2019-12-30 2022-09-05 데시페라 파마슈티칼스, 엘엘씨. 비정질 키나아제 억제제 제형 및 이의 사용 방법

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1131242A (en) 1965-02-18 1968-10-23 Gen Foods Ltd Improvements in or relating to spray-drying apparatus
DE2201111A1 (de) 1971-01-19 1972-07-27 Niro Atomizer As Zerstaeubungstrocknungsvorrichtung zur Herstellung von Pulver,z.B. Milchpulver
IT1025765B (it) 1974-11-18 1978-08-30 Gastaldi Francesco Essiccatore perfezionato a spruzzo
DE2741196A1 (de) * 1977-09-13 1979-03-15 Bayer Ag Verfahren zur herstellung von perlpolymeren
US4187617A (en) 1978-12-18 1980-02-12 Becker James J Jr Spray dryer
US4702799A (en) 1985-09-03 1987-10-27 Nestec S.A. Dryer and drying method
RU2130311C1 (ru) 1994-05-06 1999-05-20 Пфайзер Инк. Лекарственные формы азитромицина с контролируемым высвобождением
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
DE19613691A1 (de) * 1996-04-05 1997-10-09 Boehringer Ingelheim Int Arzneimittel für die Behandlung von Tumorerkrankungen
US5858409A (en) * 1996-04-17 1999-01-12 Fmc Corporation Hydrolyzed cellulose granulations for pharmaceuticals
ES2287971T3 (es) 1997-08-11 2007-12-16 Pfizer Products Inc. Dispersiones farmaceuticas solidas con biodisponibilidad incrementada.
ATE400252T1 (de) 1999-02-10 2008-07-15 Pfizer Prod Inc Pharmazeutische feste dispersionen
DE60042352D1 (de) 1999-02-10 2009-07-23 Pfizer Prod Inc Osmotisches System zur Verabreichung von Wirkstoffen, die feste amorphe Dispersionen enthalten
US6706283B1 (en) * 1999-02-10 2004-03-16 Pfizer Inc Controlled release by extrusion of solid amorphous dispersions of drugs
ES2310164T3 (es) 1999-02-10 2009-01-01 Pfizer Products Inc. Dispositivo de liberacion controlada por la matriz.
PE20011184A1 (es) 2000-03-16 2001-11-15 Pfizer Prod Inc Composiciones farmaceuticas de inhibidores de la glucogeno-fosforilasa
UY26615A1 (es) * 2000-03-16 2001-10-25 Pfizer Prod Inc Inhibidor de la glucogeno fosforilasa.
US7115279B2 (en) * 2000-08-03 2006-10-03 Curatolo William J Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
KR100758045B1 (ko) 2002-02-01 2007-09-11 화이자 프로덕츠 인크. 압력 노즐을 이용하여 균질한 분무 건조된 비결정질 고체약물 분산제를 제조하는 방법
BR0307333A (pt) * 2002-02-01 2004-12-07 Pfizer Prod Inc Métodos para a preparação de dispersões homogéneas de fármacos sólidos amorfos atomizados utilizando um sistema de secagem por pulverização

Also Published As

Publication number Publication date
TW200404576A (en) 2004-04-01
JP2005523260A (ja) 2005-08-04
RU2004123639A (ru) 2005-04-20
US20030185893A1 (en) 2003-10-02
PA8565401A1 (es) 2003-12-10
CN1787808A (zh) 2006-06-14
AU2003239463B2 (en) 2007-10-18
ZA200405971B (en) 2006-05-31
KR20040083491A (ko) 2004-10-02
PL371593A1 (en) 2005-06-27
AR038369A1 (es) 2005-01-12
BR0307515A (pt) 2004-12-07
KR100758045B1 (ko) 2007-09-11
UY27645A1 (es) 2003-09-30
US7780988B2 (en) 2010-08-24
CA2474958A1 (en) 2003-08-07
WO2003063821A2 (en) 2003-08-07
PE20030804A1 (es) 2003-09-19
EP1469830A2 (en) 2004-10-27
WO2003063821A3 (en) 2003-11-13
GT200300024A (es) 2003-09-22
RU2288703C2 (ru) 2006-12-10
MXPA04007435A (es) 2004-10-11

Similar Documents

Publication Publication Date Title
RS67304A (en) Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles
WO2007109906A8 (en) Method and apparatus for nanopowder and micropowder production using axial injection plasma spray
WO2003063822A3 (en) Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
WO2003080034A3 (de) Verfahren zur herstellung und anwendung von mikro- und nanoteilchen durch aufbauende mikronisation
WO2005000456A3 (fr) Procede de preparation de particules spheriques a base de polyamide
EP1886673A3 (en) Solid dosage form of enteric solid dispersion and method for producing the same
EP1541637A4 (en) NOVEL PROCESS FOR PRODUCING PIGMENT NANOPARTICLE
DE602004017643D1 (sr)
WO2005011636A3 (en) Spray drying processes for forming solid amorphous dispersions of drugs and polymers
WO2004058218A3 (en) Prefilming atomizer
ATE405611T1 (de) Verfahren zur herstellung von partikeln aus thermoplastischen polymeren und daraus gewonnenes pulver
AU2002223558A1 (en) Method for producing polymer coated pigment particles by precipitation
CA2430318A1 (en) Powder formulation and method for producing the same
AU2002317809A1 (en) Method for producing an aqueous dispersion of particles composed of a polymer and a fine-particle inorganic solid
WO2002083797A3 (de) Anionisch stabilisierte, wässrige dispersionen von nanopartikulärem zinkoxid, verfahren zu deren herstellung sowie deren verwendung
TW200619177A (en) Apparatus for preparing inorganic spheroidized particle
KR20010042536A (ko) 정제의 제조방법 및 정제
WO2006097725A3 (en) Pharmaceutical compositions comprising microparticles for delivery into neurons
EP1886672A3 (en) Solid dosage form comprising solid dispersion and method for producing the same
WO2003020348A1 (fr) Dispositif d'aspiration
EP1548509A3 (en) Process for producing toner, and apparatus for modifying surfaces of toner particles
JP2004300426A (ja) 微細ゲル粒子の製造方法および製造装置
WO2004047797A8 (en) Crystallization method and apparatus using an impinging plate assembly
KR102564095B1 (ko) 폴리(락티드-코-글리콜리드) 공중합체 미세입자의 제조 방법
SG153663A1 (en) Process for the production of biodegradable, functionalised polymer particles and use thereof as pharmaceutical supports